Quarterly Current Liabilities
N/A
30 September 2023
Summary:
Tekla Life Sciences Investors quarterly total current liabilities is not available.HQL Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
HQL Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
HQL Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time |
Tekla Life Sciences Investors Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | $3.54 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2021 | - | $0.00 |
FAQ
- What is the all time high quarterly current liabilities for Tekla Life Sciences Investors?
What is the all time high quarterly current liabilities for Tekla Life Sciences Investors?
Tekla Life Sciences Investors all-time high quarterly total current liabilities is $3.54 M